Starting cervical cancer screening at 25 years of age: the time has come

In 2013, the Canadian Task Force on Preventive Health Care updated its recommendations for cervical cancer screening, which included increasing the age to start screening to 25 years. Six years on, with only 2 provinces updating their guidelines accordingly, it is timely to review the relevance of t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian Medical Association journal (CMAJ) 2019-01, Vol.191 (1), p.E1-E2
Hauptverfasser: Popadiuk, Cathy, MD MBA MSL, Decker, Kathleen, PhD, Gauvreau, Cindy, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E2
container_issue 1
container_start_page E1
container_title Canadian Medical Association journal (CMAJ)
container_volume 191
creator Popadiuk, Cathy, MD MBA MSL
Decker, Kathleen, PhD
Gauvreau, Cindy, PhD
description In 2013, the Canadian Task Force on Preventive Health Care updated its recommendations for cervical cancer screening, which included increasing the age to start screening to 25 years. Six years on, with only 2 provinces updating their guidelines accordingly, it is timely to review the relevance of these recommendations, as incidence of cervical cancer in women under 25 years of age continues to be low and vaccination levels for human papillomavirus (HPV) are relatively high. Indeed, an important consideration in adopting the 2013 task force recommendations is the successful implementation of the 2007 federal HPV vaccination strategy. More than 10 years have passed since the provinces and territories started their respective HPV vaccination programs, and the first cohort of girls who were vaccinated will be 25 years old in 2019. The effect of vaccination is evident from data collected by provincial screening programs for all women screened, regardless of age, including those younger than 21 years of age.
doi_str_mv 10.1503/cmaj.181312
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6312515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A568369908</galeid><els_id>1_s2_0_S082039461930001X</els_id><sourcerecordid>A568369908</sourcerecordid><originalsourceid>FETCH-LOGICAL-c695t-4005dabb36676b82003123dabaeeec7cee6dad57b649e43e215a1093b370b8a83</originalsourceid><addsrcrecordid>eNqVk89v0zAUxyMEYmVw4o4sJqEhlOIfiZNwQJomYJMmkChI3CzHeU1dEruznWr973HU0bWoF-yDLfvjr5_9vi9JXhI8JTlm71Uvl1NSEkboo2RCsrJMKaPV42SCS4pTVmX8JHnm_RLHxmjxNDlhmJOCUj5JrmZBuqBNixS4tVayQ0qaOEdeOQAz7siAaI42IJ1Hdo5kCx9QWAAKuge0kB4p28Pz5Mlcdh5e3I-nyc_Pn35cXqU3375cX17cpIpXeUgzjPNG1jXjvOB1jA_HsFlckQCgCgXAG9nkRc2zCjIGlOSS4IrVrMB1KUt2mnzc6q6GuodGgQlOdmLldC_dRlipxeGO0QvR2rXg8aKc5FHg_F7A2dsBfBC99gq6ThqwgxeU8Dx-D8lwRM_-QZd2cCY-b6RKXLKSFA9UKzsQ2sxtvFeNouIi5yXjVYXHuNMjVAsGYpDWwFzH5QP-9RFerfSt2IemR6DYG-i1Oqr69uBAZALchVYO3ovr2ff_YL8esm_22AXILiy87YagrfGH4LstqJz13sF8lzmCxWhnMdpZbO0c6Vf7yd6xf_374AaIlltrcEJ12ow2_g0b8Lt0EeGpwGI2VsRYEKRisRjIL_YHVF7-sg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2168083817</pqid></control><display><type>article</type><title>Starting cervical cancer screening at 25 years of age: the time has come</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Popadiuk, Cathy, MD MBA MSL ; Decker, Kathleen, PhD ; Gauvreau, Cindy, PhD</creator><creatorcontrib>Popadiuk, Cathy, MD MBA MSL ; Decker, Kathleen, PhD ; Gauvreau, Cindy, PhD</creatorcontrib><description>In 2013, the Canadian Task Force on Preventive Health Care updated its recommendations for cervical cancer screening, which included increasing the age to start screening to 25 years. Six years on, with only 2 provinces updating their guidelines accordingly, it is timely to review the relevance of these recommendations, as incidence of cervical cancer in women under 25 years of age continues to be low and vaccination levels for human papillomavirus (HPV) are relatively high. Indeed, an important consideration in adopting the 2013 task force recommendations is the successful implementation of the 2007 federal HPV vaccination strategy. More than 10 years have passed since the provinces and territories started their respective HPV vaccination programs, and the first cohort of girls who were vaccinated will be 25 years old in 2019. The effect of vaccination is evident from data collected by provincial screening programs for all women screened, regardless of age, including those younger than 21 years of age.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>DOI: 10.1503/cmaj.181312</identifier><identifier>PMID: 30617226</identifier><language>eng</language><publisher>Canada: Joule Inc</publisher><subject>Adult ; Age ; Analysis ; Canada ; Canadians ; Cancer screening ; Cervical cancer ; Cost-Benefit Analysis ; Diagnosis ; Early Detection of Cancer - methods ; Female ; Health Services Research ; Human papillomavirus ; Humans ; Internal Medicine ; Mass Screening ; Medical screening ; Papanicolaou Test - statistics &amp; numerical data ; Papillomavirus Vaccines - therapeutic use ; Practice guidelines (Medicine) ; Practice Guidelines as Topic ; Preventive Medicine - economics ; Preventive Medicine - organization &amp; administration ; Systematic review ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - prevention &amp; control ; Vaccination - statistics &amp; numerical data ; Vaccines ; Womens health ; Young Adult ; Young adults</subject><ispartof>Canadian Medical Association journal (CMAJ), 2019-01, Vol.191 (1), p.E1-E2</ispartof><rights>Joule Inc. or its licensors</rights><rights>COPYRIGHT 2019 Joule Inc.</rights><rights>Copyright Joule Inc Jan 7, 2019</rights><rights>2019 Joule Inc. or its licensors 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c695t-4005dabb36676b82003123dabaeeec7cee6dad57b649e43e215a1093b370b8a83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312515/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312515/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30617226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Popadiuk, Cathy, MD MBA MSL</creatorcontrib><creatorcontrib>Decker, Kathleen, PhD</creatorcontrib><creatorcontrib>Gauvreau, Cindy, PhD</creatorcontrib><title>Starting cervical cancer screening at 25 years of age: the time has come</title><title>Canadian Medical Association journal (CMAJ)</title><addtitle>CMAJ</addtitle><description>In 2013, the Canadian Task Force on Preventive Health Care updated its recommendations for cervical cancer screening, which included increasing the age to start screening to 25 years. Six years on, with only 2 provinces updating their guidelines accordingly, it is timely to review the relevance of these recommendations, as incidence of cervical cancer in women under 25 years of age continues to be low and vaccination levels for human papillomavirus (HPV) are relatively high. Indeed, an important consideration in adopting the 2013 task force recommendations is the successful implementation of the 2007 federal HPV vaccination strategy. More than 10 years have passed since the provinces and territories started their respective HPV vaccination programs, and the first cohort of girls who were vaccinated will be 25 years old in 2019. The effect of vaccination is evident from data collected by provincial screening programs for all women screened, regardless of age, including those younger than 21 years of age.</description><subject>Adult</subject><subject>Age</subject><subject>Analysis</subject><subject>Canada</subject><subject>Canadians</subject><subject>Cancer screening</subject><subject>Cervical cancer</subject><subject>Cost-Benefit Analysis</subject><subject>Diagnosis</subject><subject>Early Detection of Cancer - methods</subject><subject>Female</subject><subject>Health Services Research</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Mass Screening</subject><subject>Medical screening</subject><subject>Papanicolaou Test - statistics &amp; numerical data</subject><subject>Papillomavirus Vaccines - therapeutic use</subject><subject>Practice guidelines (Medicine)</subject><subject>Practice Guidelines as Topic</subject><subject>Preventive Medicine - economics</subject><subject>Preventive Medicine - organization &amp; administration</subject><subject>Systematic review</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - prevention &amp; control</subject><subject>Vaccination - statistics &amp; numerical data</subject><subject>Vaccines</subject><subject>Womens health</subject><subject>Young Adult</subject><subject>Young adults</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqVk89v0zAUxyMEYmVw4o4sJqEhlOIfiZNwQJomYJMmkChI3CzHeU1dEruznWr973HU0bWoF-yDLfvjr5_9vi9JXhI8JTlm71Uvl1NSEkboo2RCsrJMKaPV42SCS4pTVmX8JHnm_RLHxmjxNDlhmJOCUj5JrmZBuqBNixS4tVayQ0qaOEdeOQAz7siAaI42IJ1Hdo5kCx9QWAAKuge0kB4p28Pz5Mlcdh5e3I-nyc_Pn35cXqU3375cX17cpIpXeUgzjPNG1jXjvOB1jA_HsFlckQCgCgXAG9nkRc2zCjIGlOSS4IrVrMB1KUt2mnzc6q6GuodGgQlOdmLldC_dRlipxeGO0QvR2rXg8aKc5FHg_F7A2dsBfBC99gq6ThqwgxeU8Dx-D8lwRM_-QZd2cCY-b6RKXLKSFA9UKzsQ2sxtvFeNouIi5yXjVYXHuNMjVAsGYpDWwFzH5QP-9RFerfSt2IemR6DYG-i1Oqr69uBAZALchVYO3ovr2ff_YL8esm_22AXILiy87YagrfGH4LstqJz13sF8lzmCxWhnMdpZbO0c6Vf7yd6xf_374AaIlltrcEJ12ow2_g0b8Lt0EeGpwGI2VsRYEKRisRjIL_YHVF7-sg</recordid><startdate>20190107</startdate><enddate>20190107</enddate><creator>Popadiuk, Cathy, MD MBA MSL</creator><creator>Decker, Kathleen, PhD</creator><creator>Gauvreau, Cindy, PhD</creator><general>Joule Inc</general><general>CMA Impact, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190107</creationdate><title>Starting cervical cancer screening at 25 years of age: the time has come</title><author>Popadiuk, Cathy, MD MBA MSL ; Decker, Kathleen, PhD ; Gauvreau, Cindy, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c695t-4005dabb36676b82003123dabaeeec7cee6dad57b649e43e215a1093b370b8a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Age</topic><topic>Analysis</topic><topic>Canada</topic><topic>Canadians</topic><topic>Cancer screening</topic><topic>Cervical cancer</topic><topic>Cost-Benefit Analysis</topic><topic>Diagnosis</topic><topic>Early Detection of Cancer - methods</topic><topic>Female</topic><topic>Health Services Research</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Mass Screening</topic><topic>Medical screening</topic><topic>Papanicolaou Test - statistics &amp; numerical data</topic><topic>Papillomavirus Vaccines - therapeutic use</topic><topic>Practice guidelines (Medicine)</topic><topic>Practice Guidelines as Topic</topic><topic>Preventive Medicine - economics</topic><topic>Preventive Medicine - organization &amp; administration</topic><topic>Systematic review</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - prevention &amp; control</topic><topic>Vaccination - statistics &amp; numerical data</topic><topic>Vaccines</topic><topic>Womens health</topic><topic>Young Adult</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Popadiuk, Cathy, MD MBA MSL</creatorcontrib><creatorcontrib>Decker, Kathleen, PhD</creatorcontrib><creatorcontrib>Gauvreau, Cindy, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business &amp; Current Affairs Database</collection><collection>Canadian Business &amp; Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>CBCA Reference &amp; Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Popadiuk, Cathy, MD MBA MSL</au><au>Decker, Kathleen, PhD</au><au>Gauvreau, Cindy, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Starting cervical cancer screening at 25 years of age: the time has come</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><addtitle>CMAJ</addtitle><date>2019-01-07</date><risdate>2019</risdate><volume>191</volume><issue>1</issue><spage>E1</spage><epage>E2</epage><pages>E1-E2</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><abstract>In 2013, the Canadian Task Force on Preventive Health Care updated its recommendations for cervical cancer screening, which included increasing the age to start screening to 25 years. Six years on, with only 2 provinces updating their guidelines accordingly, it is timely to review the relevance of these recommendations, as incidence of cervical cancer in women under 25 years of age continues to be low and vaccination levels for human papillomavirus (HPV) are relatively high. Indeed, an important consideration in adopting the 2013 task force recommendations is the successful implementation of the 2007 federal HPV vaccination strategy. More than 10 years have passed since the provinces and territories started their respective HPV vaccination programs, and the first cohort of girls who were vaccinated will be 25 years old in 2019. The effect of vaccination is evident from data collected by provincial screening programs for all women screened, regardless of age, including those younger than 21 years of age.</abstract><cop>Canada</cop><pub>Joule Inc</pub><pmid>30617226</pmid><doi>10.1503/cmaj.181312</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0820-3946
ispartof Canadian Medical Association journal (CMAJ), 2019-01, Vol.191 (1), p.E1-E2
issn 0820-3946
1488-2329
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6312515
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Age
Analysis
Canada
Canadians
Cancer screening
Cervical cancer
Cost-Benefit Analysis
Diagnosis
Early Detection of Cancer - methods
Female
Health Services Research
Human papillomavirus
Humans
Internal Medicine
Mass Screening
Medical screening
Papanicolaou Test - statistics & numerical data
Papillomavirus Vaccines - therapeutic use
Practice guidelines (Medicine)
Practice Guidelines as Topic
Preventive Medicine - economics
Preventive Medicine - organization & administration
Systematic review
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - prevention & control
Vaccination - statistics & numerical data
Vaccines
Womens health
Young Adult
Young adults
title Starting cervical cancer screening at 25 years of age: the time has come
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A42%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Starting%20cervical%20cancer%20screening%20at%2025%20years%20of%20age:%20the%20time%20has%20come&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.au=Popadiuk,%20Cathy,%20MD%20MBA%20MSL&rft.date=2019-01-07&rft.volume=191&rft.issue=1&rft.spage=E1&rft.epage=E2&rft.pages=E1-E2&rft.issn=0820-3946&rft.eissn=1488-2329&rft_id=info:doi/10.1503/cmaj.181312&rft_dat=%3Cgale_pubme%3EA568369908%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2168083817&rft_id=info:pmid/30617226&rft_galeid=A568369908&rft_els_id=1_s2_0_S082039461930001X&rfr_iscdi=true